Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
71
PharmaCompass offers a list of Levoamlodipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levoamlodipine manufacturer or Levoamlodipine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levoamlodipine manufacturer or Levoamlodipine supplier.
PharmaCompass also assists you with knowing the Levoamlodipine API Price utilized in the formulation of products. Levoamlodipine API Price is not always fixed or binding as the Levoamlodipine Price is obtained through a variety of data sources. The Levoamlodipine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levamlodipine Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levamlodipine Besylate, including repackagers and relabelers. The FDA regulates Levamlodipine Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levamlodipine Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levamlodipine Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levamlodipine Besylate supplier is an individual or a company that provides Levamlodipine Besylate active pharmaceutical ingredient (API) or Levamlodipine Besylate finished formulations upon request. The Levamlodipine Besylate suppliers may include Levamlodipine Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Levamlodipine Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levamlodipine Besylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Levamlodipine Besylate active pharmaceutical ingredient (API) in detail. Different forms of Levamlodipine Besylate DMFs exist exist since differing nations have different regulations, such as Levamlodipine Besylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levamlodipine Besylate DMF submitted to regulatory agencies in the US is known as a USDMF. Levamlodipine Besylate USDMF includes data on Levamlodipine Besylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levamlodipine Besylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levamlodipine Besylate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levamlodipine Besylate Drug Master File in Korea (Levamlodipine Besylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levamlodipine Besylate. The MFDS reviews the Levamlodipine Besylate KDMF as part of the drug registration process and uses the information provided in the Levamlodipine Besylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levamlodipine Besylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levamlodipine Besylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levamlodipine Besylate suppliers with KDMF on PharmaCompass.
Levamlodipine Besylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levamlodipine Besylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levamlodipine Besylate GMP manufacturer or Levamlodipine Besylate GMP API supplier for your needs.
A Levamlodipine Besylate CoA (Certificate of Analysis) is a formal document that attests to Levamlodipine Besylate's compliance with Levamlodipine Besylate specifications and serves as a tool for batch-level quality control.
Levamlodipine Besylate CoA mostly includes findings from lab analyses of a specific batch. For each Levamlodipine Besylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levamlodipine Besylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levamlodipine Besylate EP), Levamlodipine Besylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levamlodipine Besylate USP).
